Massachusetts Financial Services Co. MA Boosts Stake in Certara, Inc. (NASDAQ:CERT)

Massachusetts Financial Services Co. MA increased its holdings in Certara, Inc. (NASDAQ:CERT - Free Report) by 22.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,585,155 shares of the company's stock after buying an additional 475,081 shares during the period. Massachusetts Financial Services Co. MA owned 1.62% of Certara worth $45,473,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Covestor Ltd raised its position in shares of Certara by 14,940.0% in the third quarter. Covestor Ltd now owns 3,760 shares of the company's stock worth $55,000 after buying an additional 3,735 shares in the last quarter. Gamco Investors INC. ET AL bought a new position in Certara in the third quarter valued at $145,000. Pacer Advisors Inc. increased its stake in Certara by 1,704.0% in the fourth quarter. Pacer Advisors Inc. now owns 12,754 shares of the company's stock valued at $224,000 after acquiring an additional 12,047 shares during the last quarter. Truist Financial Corp increased its stake in Certara by 20.5% in the fourth quarter. Truist Financial Corp now owns 13,958 shares of the company's stock valued at $246,000 after acquiring an additional 2,372 shares during the last quarter. Finally, Natixis Advisors L.P. increased its stake in Certara by 13.4% in the third quarter. Natixis Advisors L.P. now owns 15,136 shares of the company's stock valued at $220,000 after acquiring an additional 1,791 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company's stock.

Certara Trading Down 2.4 %

Shares of Certara stock traded down $0.39 during trading on Friday, reaching $16.08. 410,192 shares of the stock were exchanged, compared to its average volume of 538,368. The company has a quick ratio of 3.26, a current ratio of 3.26 and a debt-to-equity ratio of 0.27. The stock's fifty day moving average is $17.41 and its 200 day moving average is $16.60. The firm has a market cap of $2.59 billion, a price-to-earnings ratio of -41.23, a price-to-earnings-growth ratio of 1.59 and a beta of 1.61. Certara, Inc. has a 1 year low of $11.81 and a 1 year high of $22.65.

Certara (NASDAQ:CERT - Get Free Report) last posted its earnings results on Thursday, February 29th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). The firm had revenue of $88.01 million for the quarter, compared to analysts' expectations of $86.80 million. Certara had a positive return on equity of 4.08% and a negative net margin of 17.02%. As a group, equities research analysts expect that Certara, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Transactions at Certara

In other news, insider Patrick F. Smith sold 14,427 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now directly owns 50,091 shares in the company, valued at $844,033.35. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Certara news, insider Patrick F. Smith sold 14,427 shares of the firm's stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the completion of the sale, the insider now directly owns 50,091 shares in the company, valued at $844,033.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Richard M. Traynor sold 3,000 shares of the firm's stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the sale, the senior vice president now owns 173,524 shares of the company's stock, valued at $3,123,432. The disclosure for this sale can be found here. 2.39% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CERT has been the topic of a number of research analyst reports. SVB Leerink initiated coverage on Certara in a research note on Monday, February 26th. They issued a "market perform" rating and a $19.00 target price on the stock. KeyCorp raised Certara from a "sector weight" rating to an "overweight" rating and set a $23.00 target price on the stock in a research note on Wednesday, April 10th. JMP Securities assumed coverage on Certara in a research note on Thursday, April 4th. They set a "market perform" rating on the stock. Leerink Partnrs reaffirmed a "market perform" rating on shares of Certara in a research note on Monday, February 26th. Finally, Barclays raised their price objective on Certara from $16.00 to $18.00 and gave the company an "equal weight" rating in a research note on Thursday, January 25th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $20.06.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.